Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
[WEBINAR] A masterclass in advanced analytical assays for bioanalysis of oligonucleotides 5 days 1 hours 36 mins 7 secs REGISTER NOW!

Echo® MS System for high-throughput analysis

2 Nov 2020
Written by SCIEX
Drug development MS (LC–MS/MS, HRMS, IMS)

This presentation outlines the analytical challenges in MS-based screening, acoustic ejection mass spectrometry technology and the application of the Echo® MS System beyond drug discovery and development.

 

SPOTLIGHT-Echo-MS press-release slides-Chang-min


This content was supplied by SCIEX. 

Top content

  • Novel microchip system mEM speeds up antibody analysis
  • Healthcare, finance and smart materials experts deliver opening and closing plenaries at PharmSci 360
  • eBook: Celebrating 50 years of ion chromatography

Related tags

LC-MS sciex
Previous article

Related articles

15 MAR 2016 GENERAL INTEREST
Simple, standardized, and sensitive quantification of Bevacizumab (Avastin) using ProteinWorks eXpress Digest Kits
30 NOV 2009 CHROMATOGRAPHY
Conference report: 1st Australasian Symposium on Metabolomics
2 JUN 2020 DRUG DEVELOPMENT
New Echo® MS system announced by SCIEX at ASMS 2020 Reboot
30 AUG 2017 JOURNAL ARTICLES
The validation of an LC–MS/MS assay for perhexiline and major hydroxy metabolites, and its application to therapeutic monitoring in patient plasma
28 JUN 2011 CHROMATOGRAPHY
In vivo solid-phase microextraction sampling: a promising future
17 MAY 2016 LARGE MOLECULES
Convergence of LBA/LC–MS in bioanalysis of large molecules – Part 2
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone